As the global economy mends, the 2021 growth of HIV Diagnostics will have significant change from previous year. According to our (LP Information) latest study, the global HIV Diagnostics market size is USD million in 2022 from USD 2578.9 million in 2021, with a change of % between 2021 and 2022. The global HIV Diagnostics market size will reach USD 4660.9 million in 2028, growing at a CAGR of 8.8% over the analysis period.
The United States HIV Diagnostics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global HIV Diagnostics market, reaching US$ million by the year 2028. As for the Europe HIV Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main HIV Diagnostics players cover Abbott, Abbott Healthcare, Abbvie Inc., and Brsitol-Myers Squibb, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of HIV Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Consumables
Assay, Kits and Reagents
Other Consumables
Instruments
Software and Services
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abbott
Abbott Healthcare
Abbvie Inc.
Brsitol-Myers Squibb
Janssen Therapeutics
Gilead Sciences
Merck & Co. Inc
VIIV Healthcare
BD Biosciences
Beckman Coulter
Partec
Sysmex
Apogee Flow Systems
PointCare Technologies Inc.
Zyomyx Inc.
Mylan inc.
Roche Diagnostics
Siemens Healthcare
Qiagen
BioMerieux